Search Results

Quantification of residual plasmid DNA and SV40 promoter-enhancer sequences in Pfizer/BioNTech and Moderna modRNA COVID-19 vaccines from Ontario, Canada.

• Authors : Speicher, David J.¹ (AUTHOR) ; Rose, Jessica² (AUTHOR); McKernan, Kevin³ (AUTHOR)

• Source: Autoimmunity. Dec2025, Vol. 58 Issue 1, p1-20. 20p.

Record details

A data-driven machine learning framework to predict side effects of AstraZeneca and sinopharm COVID-19 vaccines.

• Authors : Eterafi, Majid^1,2 (AUTHOR); Fouladi, Nasrin³ (AUTHOR); Amanzadeh, Masoud⁴ (AUTHOR)

• Source: Scientific Reports. 11/19/2025, Vol. 15 Issue 1, p1-19. 19p.

Record details

Long-term trends in reporting of cardiac adverse drug reactions to COVID-19 vaccines - an exploratory analysis of the EudraVigilance database.

• Authors : Nazar, Wojciech^1,2 (AUTHOR) ; Romantowski, Jan² (AUTHOR); Nazar, Grzegorz¹ (AUTHOR)

• Source: BMC Infectious Diseases. 11/14/2025, Vol. 25 Issue 1, p1-14. 14p.

Record details

Immunogenicity of JN.1- and KP.2-Encoding mRNA COVID-19 Vaccines Against JN.1 Subvariants in Adult Participants.

• Authors : Figueroa, Amparo L¹ (AUTHOR); Girard, Bethany¹ (AUTHOR); Edwards, Darin K¹ (AUTHOR)

• Source: Open Forum Infectious Diseases. Dec2025, Vol. 12 Issue 12, p1-5. 5p.

Record details

Cross-national disparities in healthcare workers' perceptions: Examining fear of infection and confidence in the received COVID-19 vaccines amid emerging variants.

• Authors : Hussein M; Clinical Research Administration, Alexandria Health Affairs Directorate, Alexandria, Egypt.; Ministry of Health and Population, Cairo, Egypt.

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; COVID-19*/COVID-19*/COVID-19*/psychology ; COVID-19*/COVID-19*/COVID-19*/virology SARS-CoV-2 variants

• Source: PloS one [PLoS One] 2025 Dec 12; Vol. 20 (12), pp. e0318788. Date of Electronic Publication: 2025 Dec 12 (Print Publication: 2025).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

Record details

Effectiveness of 2024-2025 COVID-19 Vaccines in Children in the United States - VISION, August 29, 2024-September 2, 2025.

• Authors : Irving SA; Rowley EAK; Chickery S

Subjects: COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/administration & dosage ; COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/immunology ; COVID-19*/COVID-19*/COVID-19*/prevention & control

• Source: MMWR. Morbidity and mortality weekly report [MMWR Morb Mortal Wkly Rep] 2025 Dec 11; Vol. 74 (40), pp. 607-614. Date of Electronic Publication: 2025 Dec 11.Publisher: U.S. Centers for Disease Control Country of Publication: United States NLM ID: 7802429 Publication Model: Electronic Cited Medium: Internet

Record details

Answering your questions about the safety and effectiveness of COVID-19 vaccines.

• Authors : National Center for Immunization and Respiratory Diseases (U.S.)

Subjects: COVID-19 vaccines -- United States.; COVID-19 vaccines -- Safety measures. -- United States; COVID-19 vaccines -- Government policy -- United States.

Record details

Answering your questions about the new COVID-19 vaccines.

• Authors : National Center for Immunization and Respiratory Diseases (U.S.)

Subjects: COVID-19 vaccines -- United States.; COVID-19 vaccines -- Safety measures. -- United States; COVID-19 vaccines -- Government policy -- United States.

Record details

Serious Adverse Drug Reactions to COVID-19 Vaccines in the Pediatric Population: A Retrospective, Cross-Sectional Study Utilizing the Eudravigilance Database for the European Economic Area.

• Authors : Nazar, Grzegorz¹ (AUTHOR); Olszlegier, Julia^1,2 (AUTHOR); Kamińska, Aleksandra^1,3 (AUTHOR)

• Source: Journal of Clinical Medicine. Sep2025, Vol. 14 Issue 18, p6542. 16p.

Record details

Acceptance, perceptions, and compliance for COVID-19 vaccines among students attending a rural university: An interventional study using brief video messages.

• Authors : Harris Bozer AL; Department of Neuroscience, Tarleton State University, Stephenville, Texas, USA.; Gandhi S

Subjects: COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/therapeutic use ; COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/administration & dosage ; COVID-19*/COVID-19*/COVID-19*/prevention & control

• Source: Journal of American college health : J of ACH [J Am Coll Health] 2025 Dec; Vol. 73 (10), pp. 4056-4070. Date of Electronic Publication: 2025 Mar 10.Publisher: Routledge Country of Publication: United States NLM ID: 8214119 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details